The role of constitutive activation of FMS-related tyrosine kinase-3 and NRas/KRas mutational status in infants with KMT2A-rearranged acute lymphoblastic leukemia

HAEMATOLOGICA

FERRATA STORTI FOUNDATION

1. European Union [HEALTH-F2-2011-261474]
2. Madeleine Schickedanz-Kinderkrebs-Stiftung
3. Deutsche Krebshilfe e. V.
4. Wilhelm-Sander Stiftung